Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Original Article

M. Husain, A.L. Birkenfeld, M. Donsmark, K. Dungan, F.G. Eliaschewitz, D.R. Franco, O.K. Jeppesen, I. Lingvay, O. Mosenzon, S.D. Pedersen, C.J. Tack, M. Thomsen, T. Vilsbøll, M.L. Warren, and S.C. Bain

N Engl J Med 2019;381:841-851

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/28/2019
Course expires: 
08/29/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, August 29, 2021 - 11:59pm.